Form D · Pharmaceuticals

Axxess Compounding II, LLLP

Missoula, MT · CIK 0001595664

Offering snapshot reported Nov 6, 2014 · SEC filing

Reported sold
$355K
Offering amount: $25.5M
Investors reported
33
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Oct 8, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$178K$355KJan 29, 2014: $250,000.00Jan 29, 2014Nov 6, 2014: $355,000.00Nov 6, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$250,000 → $355,000
  • Reported investors22 → 33

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 6, 2014Amendment$355,000$105,000vs Jan 29, 201433SEC filing
Jan 29, 2014Initial$250,000No comparison22SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-210929

Source: Form D, filed Nov 6, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Frances X Riegler Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
3819 Stephens Avenue, #201
Missoula, MT, 59801